Literature DB >> 11818156

Time-resolved fluorometric immunoassay for rubella antibody--a useful method for serosurveillance studies.

P A Christopher Maple1, Cerys S Jones.   

Abstract

Rubella antibody (IgG) has been measured in females reporting for antenatal screening using single radial haemolysis (SRH) and time-resolved fluorescence immunoassay (TRFIA). We have shown TRFIA to be a simple, specific, highly sensitive, quantitative assay for rubella IgG with a lower limit of detection of 0.2IU/ml. Out of 506 sera tested by SRH, 18 (3.6%) had low levels of antibody (< 15IU/ml) compared to 83 (16.4%) tested by TRFIA and, of these, 32 (6.3%) had rubella antibody concentrations < 10IU/ml. The lowest level (3.1%) of rubella susceptibility (antibody levels < 10IU/ml) was found in females aged 25-29 and the highest level of susceptibility (23.5%) occurred in females aged 40 years, and over. Geometric mean rubella antibody concentrations (IU/ml) were 26.8, 34.4, 34.8, 29.7, 27.5 and 20.0 for age groups <20, 20-24, 25-29, 30-34, 35-39 and > or =40 years, respectively. Our rubella vaccination policies have built up good levels of rubella immunity in women of childbearing age in our locality, and using TRFIA technology we can accurately monitor changes over time.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818156     DOI: 10.1016/s0264-410x(01)00474-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Application of a noninvasive oral fluid test for detection of treponemal IgG in a predominantly HIV-infected population.

Authors:  P A C Maple; I Simms; G Kafatos; M Solomou; K Fenton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

2.  Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescence in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infection.

Authors:  C S Jones; P A C Maple; N J Andrews; I D Paul; E O Caul
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

3.  Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay.

Authors:  P A C Maple; J Gray; J Breuer; G Kafatos; S Parker; D Brown
Journal:  Clin Vaccine Immunol       Date:  2006-02

4.  Collection tubes with or without gel separator did not interfere with detection of rubella virus antibodies IgM and IgG.

Authors:  L C Oliveira; K H Kawasato; M S Otta; L P Lima; T S Okay
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 5.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.